The long-predicted surge of merger and acquisition activity has finally struck the highly fragmented life sciences sector. This KnowledgeLine explores the consolidation mania sweeping through the biotech industry— a trend that is already transforming how life sciences companies secure the resources needed to build sustainable businesses and develop innovative medical products.
|
|
